Table 2.
Levels of serum biochemistry in ANH and AHH
| ANH | AHH | |
|---|---|---|
| Creatinine (mg/dL) | ||
| T0 | 0.2 ± 0.00 | 0.2 ± 0.01 |
| T2 | 0.4 ± 0.02**† | 0.2 ± 0.04 |
| BUN (mg/dL) | ||
| T0 | 12.5 ± 2.1 | 15.8 ± 3.5 |
| T2 | 30.7 ± 3.2**† | 15.1 ± 1.2 |
| Lactate (mmol/L) | ||
| T0 | 1.4 ± 0.2 | 1.9 ± 0.4 |
| T2 | 6.2 ± 0.9**† | 3.8 ± 1.3 |
| ANP (pg/mL) | ||
| T0 | 25.1 ± 1.7 | 27.1 ± 5.1 |
| T2 | 66.2 ± 11.6* | 55.4 ± 5.2*** |
| MDA (mmol/L) | ||
| T0 | 0.4 ± 0.1 | 0.4 ± 0.1 |
| T2 | 1.6 ± 0.2* | 1.5 ± 0.4* |
| IMA (ABSU) | ||
| T0 | 0.8 ± 0.03 | 0.8 ± 0.01 |
| T2 | 1.1 ± 0.10* | 0.9 ± 0.03 |
| Free haemoglobin (g/L) | ||
| T0 | 0.005 ± 0.002 | 0.007 ± 0.003 |
| T2 | 0.042 ± 0.017* | 0.051 ± 0.011* |
| Syndecan-1 (ng/mL) | ||
| T0 | 4.2 ± 1.8 | 6.7 ± 2.5 |
| T2 | 8.9 ± 2.7* | 11.7 ± 3.7* |
| TNF-α (pg/mL) | ||
| T0 | 31.4 ± 11.0 | 22.2 ± 8.3 |
| T2 | 177.1 ± 25.7** | 147.0 ± 25.2** |
ANH: acute normovolemic haemodilution; AHH: acute hypervolemic haemodilution; ANP: atrial natriuretic peptide; MDA: malondialdehyde; IMA: ischaemia modified albumin; TNF-α: tumour necrosis factor-alpha. *P < 0.05, **P < 0.01, ***P < 0.001 vs. T0, †P < 0.05 vs. AHH.